21 May 2009
Memory and executive functions in patients after transplantation treated with different immunosuppressive drugs
L Gawryś, G Senatorski, L Pączek, L KaczmarekAnn Transplant 2009; 14(1): 75-75 :: ID: 880475
Abstract
Background: Rapamycin (Sirolimus) is an immunosuppressive drug used in
pharmacotherapy of patients after transplantation. The aim of the study was to investigate memory of patients after transplantation, which undergo the immunosuppressive pharmacotherapy with rapamycin. Rapamycin inhibits mTOR protein kinase, which is one of the key regulators of translational capacity. It was repeatedly shown that mTOR kinase is involved in synaptic plasticity mechanisms and long term memory formation.
Material/Methods: This study examined memory functions in three groups of patients after transplantation taking different immunosuppressive drugs: rapamycin (n=18), cyclosporine (n=15), mycophenolate mofetil (n=18) and group of 19 control subjects. Two procedural (Mirror Reading and Serial Reaction Task) and one declarative task (Auditory Verbal Learning Test) were employed in order to measure acquisition and retention of information. Since memory performance may be reduced owing to executive dysfunction, four measures of cognitive control were included in the study: Trial Making Test, Stroop Test, Wisconsin Card Sorting Test and Digit Span.
Results: The performance of memory tasks and tests of executive function did not differ in the three patients groups and there was no effect of immunosuppressive treatment used. No decrease of memory and executive function was found in patients after transplantation in comparison with the
healthy control subjects.
Conclusions: Immunosuppressive therapy had no effect on cognitive functions in studied patients group.
Keywords: Immunosuppression
In Press
Original article
The Long-Acting Glucagon-Like Peptide-2 Analog Apraglutide Enhances Intestinal Protection and Survival Afte...Ann Transplant In Press; DOI: 10.12659/AOT.945249
Original article
Biopsychosocial Effects of Donor Traits on Heart Transplant RecipientsAnn Transplant In Press; DOI:
Clinical Research
Ten-Year Retrospective Analysis of Continuous Renal Replacement Therapy in Burn Patients: Impact on Surviva...Ann Transplant In Press; DOI:
Original article
Factors Influencing Stress Disorders in Intensive Care Unit (ICU) Patients After Liver Transplantation: A C...Ann Transplant In Press; DOI: 10.12659/AOT.944320
Most Viewed Current Articles
05 Apr 2022 : Original article 13,113
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 10,260
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
12 Jan 2022 : Original article 9,611
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
15 Mar 2022 : Case report 7,271
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860